<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"adverse effects":2,
"dipeptidyl peptidase-4 inhibitors":1,
"glucagon-like peptide 1 receptor agonists":1,
"new antidiabetic agents":1,
"sodium-glucose cotransporter 2 inhibitors":1,
"antithyroglobulin antibody":2,
"difficulty":1,
"thyroidectomy":19,
"Iodine":1,
"Thyroid cancer":73,
"Thyroid nodules":13,
"cancer":20,
"coping":2,
"latina women":1,
"latino men":1,
"survivors":1,
"Clinical–histopathological features":1,
"Environmental factors":1,
"Tumourigenesis induction":1,
"Alcohol drinking":1,
"Case-control studies":2,
"Cohort studies":1,
"Meta-analysis":7,
"Thyroid neoplasms":27,
"ERα crosstalk":1,
"integrin αvβ3":2,
"ovarian cancer":1,
"thyroid hormone":1,
"Medullary thyroid cancer":8,
"biological behavior":1,
"prognosis":17,
"recurrence":11,
"ultrasonography":10,
"Combination":1,
"Contrast-enhanced ultrasound":2,
"Improved TI-RADS":1,
"TI-RADS":3,
"body fluid cytology":1,
"cell transfer":1,
"immunocytochemistry":2,
"immunohistochemistry":15,
"microarray":2,
"MGUS":1,
"Myeloma":1,
"Waldenström macroglobulinemia":1,
"secondary malignancies":1,
"Lateral neck node metastasis":1,
"Modified radical neck dissection":1,
"Oncologic outcome":1,
"Papillary thyroid cancer":17,
"Robotic surgery":1,
"Anaplastic thyroid carcinoma":9,
"Epithelial-mesenchymal transition":1,
"Neoplastic stem cells":1,
"Receptor Notch1":1,
"antigastric parietal cell antibody":1,
"antithyroid microsomal antibody":1,
"desquamative gingivitis":1,
"erosive oral lichen planus":1,
"BMI":1,
"Obesity":2,
"Papillary thyroid carcinoma":43,
"calcitonin":1,
"calcitonin gene–related peptide":1,
"neuroendocrine":1,
"thyroid":37,
"Parathyroid adenoma":2,
"Perrier classification":1,
"[99mTc]MIBI SPECT/CT":1,
"Granular cell tumour":1,
"Neurohypophysis":1,
"Pituicytoma":1,
"S100-protein":1,
"Spindle cell oncocytoma":1,
"TTF-1":3,
"Vimentin":1,
"99mTc-MIBI":1,
"Autonomously functioning thyroid nodules":1,
"Parathyroid carcinoma":2,
"Parathyroid scintigraphy":1,
"DNA laddering":1,
"apoptosis":8,
"cell cycle":3,
"cytotoxicity":1,
"organotin(IV) compounds":1,
"adverse reactions":1,
"intraoperative radiotherapy":1,
"pilot study":1,
"radiation therapy":4,
"18FDG PET/CT":1,
"Differentiated thyroid cancer":18,
"Metastases":3,
"Tumor growth rate":1,
"biological marker":1,
"programmed death-ligand 1":1,
"survival analysis":4,
"Anti-thyroglobulin autoantibodies":1,
"Positron emission tomography":1,
"Thyroglobulin":7,
"Aggressive":1,
"Family history":1,
"Hereditary":1,
"Medullary thyroid carcinoma":10,
"Multiple endocrine neoplasia 2":1,
"Arab":1,
"Breast":3,
"Mutation":4,
"TP53":1,
"disease-free survival":5,
"dynamic risk stratification":1,
"low risk":1,
"clinical significance":1,
"solid variant":2,
"Goitre":1,
"Medical diagnosis":1,
"Painting":1,
"de Ribera":1,
"fine-needle aspiration cytology":3,
"thyroid nodule":17,
"FN1":1,
"Invasion":7,
"SphK1":1,
"miR-144-3p":1,
"Extranodal invasion":1,
"Level I":1,
"Lymph node metastases":1,
"Neck dissection":10,
"discordant cancer":1,
"familial cancer":1,
"familial risk":1,
"population impact":1,
"American Thyroid Association":1,
"dynamic risk estimates":1,
"outcome":2,
"structural persistent disease":1,
"BAP1":1,
"China":2,
"IHC":1,
"Mesothelioma":2,
"Calcitonin amyloid (ACal)":1,
"amyloid-associated glomerulopathy":1,
"case report":4,
"decreased kidney function":1,
"kidney amyloidosis":1,
"nephrotic syndrome":1,
"proteinuria":1,
"renal biopsy":1,
"systemic amyloidosis":1,
"Cohort study":1,
"malignancy":6,
"osteoporosis":1,
"population-based":1,
"athyreotic patients":1,
"levothyroxine":1,
"thyrotropin":1,
"triiodothyronine":4,
"Cushing's syndrome":1,
"RET":5,
"hypercortisolism":1,
"vandetanib":2,
"computer-aided system":1,
"ultrasound":13,
"bone":3,
"neoplasm metastasis":2,
"131I":3,
"PARP-1":1,
"SLC6A9-5:2":1,
"lncRNA":1,
"basal cell carcinoma":1,
"deiodinases":1,
"thyroid hormone metabolism":1,
"immune-related adverse event":1,
"immunotherapy":4,
"ipilimumab":1,
"nivolumab":1,
"pembrolizumab":1,
"histopathology":2,
"hysterectomy":1,
"NIFTP":4,
"RAS":6,
"fine-needle aspiration":6,
"follicular variant of papillary thyroid carcinoma":3,
"molecular testing":3,
"ATA guidelines":1,
"Bethesda":3,
"FNA":4,
"cytology":9,
"ultrasound needle biopsy":1,
"ATC":1,
"Migration":3,
"PIK3CD":1,
"miR-125b":1,
"active surveillance":3,
"overdiagnosis":3,
"Children":3,
"Nodule":1,
"Lifestyle":1,
"Rosacea":1,
"Skin disease":1,
"follicular variant":6,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":4,
"radioactive iodine":4,
"distant metastasis":4,
"long-term":1,
"temporal pattern":1,
"Adverse event":1,
"Dose interruption":1,
"Dose reduction":1,
"Lenvatinib":4,
"aggressive phenotype":1,
"antibody-drug conjugate":1,
"dysadherin":1,
"treatment":3,
"ADC to SCC transdifferentiation":1,
"S100A7":1,
"YAP":1,
"lung cancer cells":1,
"the Hippo pathway":1,
"Cell migration":1,
"Cell viability":1,
"Doxorubicin":2,
"Resistance":1,
"Thyroid carcinoma":25,
"PKA Cα":1,
"cell proliferation":1,
"p21-activated kinase 4":1,
"thyroid-stimulating hormone":1,
"Afirma":2,
"Bethesda classification":2,
"atypia of undetermined significance (AUS)":2,
"follicular lesion of undetermined significance (FLUS)":2,
"malignancy risk":1,
"C-cell carcinogenicity":1,
"GLP-1r agonists":1,
"PKPD modelling":1,
"Pharmacology":1,
"Prediction":1,
"Bone morphogenetic protein 4":1,
"Tumor progression":1,
"EFVPTC":1,
"Endocrine":3,
"Follicular neoplasm":2,
"HBME-1":1,
"Spindled lesion":1,
"fine needle aspiration":4,
"thyroid papillary microcarcinoma":2,
"BRAF":5,
"RET/PTC":1,
"TERT promoter":1,
"disease-specific survival":1,
"genetic alteration":1,
"rearrangement":2,
"relapse":1,
"survival":8,
"FOXO3a":1,
"Proteasome inhibitor MG132":1,
"Papillary thyroid carcinoma variant":1,
"Thyroid cancer, papillary":1,
"TCGA data":1,
"VDR mRNA":1,
"vitamin D":1,
"anaplastic":2,
"follicular":2,
"medullary":2,
"papillary":4,
"patient-reported outcomes":1,
"quality of life":4,
"lymph node":3,
"metastasis":10,
"skip metastasis":1,
"Biomarkers":2,
"Clinical trial":1,
"Phase 3":1,
"Tyrosine kinase inhibitor":3,
"Head and Neck Neoplasms":3,
"Incidental Findings":1,
"Thyroid tumours":1,
"molecular":2,
"morphology":1,
"ITIH5":1,
"Metastasis suppressor":1,
"Pancreatic cancer":2,
"RNAi screen":1,
"Anatomy pathology":1,
"Intra-thyroid metastasis":1,
"Métastase intra-thyroïdienne, Anatomie-pathologie, Immunohistochimie":1,
"2017":1,
"Forecasting":1,
"Incidence":4,
"Korea":1,
"Mortality":5,
"Neoplasms":4,
"cribriform-morular":1,
"papillary carcinoma":10,
"review":1,
"CEACAM1":1,
"SHP-1":1,
"Src family kinases":1,
"mast cell":1,
"Hypothyroidism":7,
"Predictive factor":1,
"Progression-free survival":2,
"Renal cell carcinoma":3,
"Sunitinib":2,
"adrenocortical carcinoma":1,
"daganat-biomarker":1,
"mellékvesekéreg-carcinoma":1,
"microRNA":2,
"mikroRNS":1,
"ovarian neoplasm":1,
"pajzsmirigydaganat":1,
"petefészek-daganat":1,
"thyroid neoplasm":3,
"tumor biomarker":1,
"PD-L1":2,
"PTC":4,
"Protein biomarker":1,
"Anastomosing channels":1,
"metastasis, miR-199a-3p":1,
"Afirma® Gene Expression Classifier":1,
"Indeterminate thyroid nodules":1,
"Ultrasound-guided fine-needle aspiration":1,
"Bax/BcL-2 ratio":1,
"Myricetin":1,
"human anaplastic thyroid cancer cells":1,
"ATM":1,
"Breast tumor resembling tall cell variant of papillary thyroid carcinoma":1,
"CK5":1,
"ER":2,
"IDH2":1,
"Myoepithelial markers":1,
"PIK3CA mutations":1,
"Reverse nuclear polarity":1,
"Solid papillary neoplasm":1,
"Lymph node size":1,
"Ratio of lymph node":1,
"Risk stratification":3,
"Serological markers":1,
"Thyroid malignancy":2,
"Thyroxine":1,
"fine-needle-aspiration":1,
"non-specific adsorption":1,
"washout":1,
"Protein tyrosine phosphatase 1B (PTP1B)":1,
"Signal transduction and activator of transcription 3 (STAT3)":1,
"Breast cancer":15,
"Tumorigenesis":2,
"cell cycle progression":1,
"proliferation":7,
"protein arginine methyltransferase 5":1,
"fine needle aspiration cytology (FNAC)":1,
"gene expression classifier":1,
"indeterminate lesions":1,
"microRNAs (miRNAs)":1,
"next generation sequencing":2,
"radiotherapy":7,
"Endoscopic dacryocystorhinostomy":1,
"nasolacrimal duct obstruction":1,
"SURGERY":13,
"hypoxia inducible factor 1 alpha":1,
"oncology":4,
"tissue microarray":2,
"fucosidase":1,
"glycosylation":1,
"Appraisal":1,
"Healthcare decisionmaking":1,
"Mcda":1,
"CC":1,
"PKM2":2,
"miR-let-7a":1,
"Lymphoma":2,
"Sjögren syndrome":1,
"ADC histogram analysis":1,
"Ki-67":1,
"diffusion weighted imaging":1,
"histopathologic features":1,
"lymphatic metastatic spread":1,
"p53":3,
"Nanostring":1,
"RET/PTC gene rearrangement":1,
"RT-PCR":1,
"air-dried FNA specimen":1,
"Consumptive hypothyroidism":1,
"Hemangioma":1,
"Liothyronine":1,
"Type 3 deiodinase":1,
"Goitre, Hyperthyroidism, Hypothyroidism, Thyroid nodules":1,
"GATA":1,
"chemosensitivity":1,
"database mining":1,
"prognostic values":1,
"SEER":2,
"breast cancer subtypes":1,
"distant metastases":1,
"ST8SIA4":1,
"follicular thyroid carcinoma":4,
"miR-146a":1,
"miR-146b":1,
"Colon cancer":2,
"Rectal cancer":1,
"Thyroid metastasis":2,
"BRCA1":1,
"Hereditary breast cancer":1,
"Peroxisome-proliferator activated Receptor γ (PPARγ)":1,
"Retinoid X Receptor (RXR)":1,
"Vitamin D Receptor (VDR)":1,
"funding":1,
"global burden of disease":1,
"global health":1,
"research and development":1,
"research investment":1,
"hormones":1,
"lungs":1,
"sex-related differences":1,
"tumor":1,
"Risk of malignancy":1,
"Total thyroidectomy":5,
"Lymph node between sternocleidomastoid and sternohyoid muscle":1,
"Risk factors":5,
"Carcinoma, papillary":7,
"Postoperative complications":1,
"Reoperation":1,
"Lymphatic metastasis":5,
"Previvors":1,
"Practice guidelines":1,
"Endodermal sinus tumor":1,
"Malignant tumor":1,
"Pleuropulmonary blastoma":1,
"Squamous cell carcinoma of lung":1,
"Thyroid papillary carcinoma":2,
"Hurthle cell":2,
"Metastatic lymph node":1,
"Hashimoto’s disease":1,
"Hashimoto’s thyroiditis":3,
"autoimmune thyroid disease":1,
"autoimmune thyroiditis":2,
"cancer genes":1,
"lipid metabolism":1,
"radiation":3,
"Pi3K":1,
"combination treatment":1,
"genetically engineered mice":1,
"15-deoxy-Δ12,14-prostaglandin J2":1,
"adherens junction":1,
"focal adhesion complex":1,
"cluster of differentiation 26":1,
"glucagon-like peptide-1 receptor":1,
"thyroid C-cell":1,
"Cutoff":1,
"Fine-needle aspirate":1,
"diagnosis":9,
"Cutaneous adenoid cystic carcinoma":1,
"Lung metastases":1,
"Thyroid transcription factor 1":2,
"Genetic":2,
"genotype-phenotype correlation":2,
"multiple endocrine neoplasia type 2":1,
"neurofibromatosis type 1":1,
"paraganglioma":4,
"von Hippel-Lindau disease":1,
"embolization":1,
"hypervascular":1,
"metastases of unknown origin":1,
"preoperativve":1,
"spinal cord compression":1,
"spinal metastases":1,
"spine surgery":1,
"thoracic":1,
"thyroid follicular carcinoma":1,
"chemotherapy":7,
"imaging":1,
"management":3,
"pathology":3,
"radioiodine":5,
"HER2/neu":1,
"PLA2G16":1,
"autoantigens":1,
"autoimmunity":1,
"central nervous system":1,
"immune repertoire":1,
"immunological homunculus":1,
"natural autoantibodies":1,
"paraneoplastic syndrome":1,
"synapse":1,
"Hurthle cell adenoma":1,
"PET/MRI":1,
"PSMA":1,
"prostate carcinoma":1,
"Iodine-123 metaiodobenzylguanidine":1,
"multiple endocrine neoplasia":1,
"pheochromocytoma":2,
"rearranged during transfection":1,
"Bifrontal craniotomy":1,
"Dura":1,
"Meningioma":2,
"Scalp":1,
"parathyroidectomy":2,
"primary hyperparathyroidism":5,
"BMT":1,
"clinical decision making":1,
"follicular lymphoma":1,
"positron emission tomography with computed tomography":1,
"thyroid incidentaloma":3,
"Lymph vessels":1,
"Medullary carcinoma":1,
"Follicular carcinoma":3,
"Nodule in nodule":1,
"amphioxus":1,
"glycoprotein hormone":1,
"thyroid gland":7,
"thyrostimulin":1,
"Endoscopic":1,
"Minimally invasive":2,
"Neurosurgery":1,
"Transsphenoidal":1,
"Struma ovarii":1,
"malignant ovarian goiter":1,
"NEM2A":1,
"NEM2B":1,
"HABP2":2,
"non-medullary thyroid cancer":1,
"p G534E":1,
"sporadic papillary thyroid carcinoma":1,
"NSCLC":3,
"histologic type":1,
"prognostic factor":1,
"RGD peptide":1,
"lung cancer":5,
"osteolytic metastasis":1,
"targeted imaging":1,
"carcinoid":1,
"gastroenteropancreatic neuroendocrine tumors":1,
"neuroendocrine tumor":1,
"octreotide":1,
"pNET":1,
"radiolabeled therapy":1,
"somatostatin analogues":1,
"Autoimmune":1,
"Blood Coagulation Factors":1,
"Fibrinolysis":1,
"Hashimoto Disease":1,
"Hyperthyroidism":3,
"Myxedema":1,
"Thyroiditis":2,
"Venous Thromboembolism":2,
"Diethylnitrosamine":1,
"Mouse model":1,
"HLA class I antigens":1,
"Immune checkpoint":1,
"NIBIT 2016":1,
"Targeted therapy":6,
"Fluorescence intensity":1,
"Gastric cancer":4,
"Indocyanine green":2,
"Near-infrared fluorescence imaging":1,
"Sentinel node navigation surgery":1,
"Bone metastases":1,
"Fractura patológica":1,
"Lesiones líticas":1,
"Lytic lesions":1,
"Metástasis óseas":1,
"Pathological fracture":1,
"Colorectal cancer":1,
"STAT3":1,
"lnc-DILC":1,
"hsa-miR-193b":1,
"laryngal neoplasms":1,
"squamous cell carcinoma":2,
"APC gene":1,
"breast implants":1,
"cribriform-morular papillary thyroid carcinoma":1,
"familial adenomatous polyposis":1,
"fibromatosis":1,
"β-catenin":1,
"Carcinoma thyroid":1,
"I-131 isolation rooms":1,
"lead glass window":1,
"stray radiations":1,
"Immune checkpoint inhibitors":1,
"Thyrotoxicosis":1,
"Toxicity":2,
"Tyrosine kinase inhibitors":4,
"dysphagia":1,
"esophagus":1,
"schwannoma":1,
"lobectomy":2,
"nodulectomy":1,
"single thyroid nodule":1,
"anti-thyroglobulin antibody":1,
"Carcinoma espinocelular":1,
"Faringectomia":1,
"Hipofaringe":1,
"Hypopharynx":2,
"Laringe":1,
"Laringectomia":1,
"Laryngectomy":2,
"Larynx":3,
"Pharyngectomy":1,
"Tireoidectomia":1,
"glottic cancer":1,
"BRAFV600E":2,
"NADPH oxidase":1,
"NIS":1,
"NOX4":1,
"ROS":1,
"Protein kinase A":1,
"cAMP analogs":1,
"BRAF V600E mutation":1,
"Liquid-based cytology":2,
"MCTs":1,
"Plump cells":1,
"Thyroid lesions":2,
"ACTH = adrenocorticotropic hormone":1,
"B-cell":1,
"DLBCL = diffuse large B-cell lymphoma":1,
"GHRH = growth hormone–releasing hormone":1,
"IGF-1 = insulin-like growth factor-1":1,
"NHL = non-Hodgkin lymphoma":1,
"PCNSL = primary central nervous system lymphoma":1,
"R-CHOP = rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone":1,
"SIADH = syndrome of inappropriate antidiuretic hormone":1,
"TSH = thyroid-stimulating hormone":1,
"pituitary surgery":1,
"somatotroph hyperplasia":1,
"diffuse optical tomography, light propagation in tissues, radiative transfer equation, thyroid cancers in human neck":1,
"CME":1,
"Complete mesocolic excision":1,
"Gastrocolic trunk":1,
"Laparoscopy":1,
"Transverse colon cancer":1,
"extrathyroidal extension":1,
"AFM":1,
"Cancer cells":2,
"Polyacrylamide gels":1,
"Stress relaxation":1,
"Viscoelastic properties":1,
"dosimetry":2,
"radionuclide therapy":2,
"Laryngeal cancer":1,
"differentially expressed genes":1,
"feature genes":1,
"support vector machine":1,
"axillary lymph node metastasis":1,
"nomogram":1,
"prediction model":1,
"Familial non-medullary thyroid cancer":1,
"G534E":1,
"Italian population":1,
"Cytopathology":1,
"Geriatric":1,
"DTC":1,
"DxWBS":1,
"Follow-up":1,
"sTg":1,
"BRAF mutation":3,
"fine-needle aspiration biopsy":1,
"morphometry":1,
"undetermined cytology":1,
"PD-1":1,
"Polymorphism":4,
"complications":3,
"readmission":1,
"smoking":2,
"National Cancer Data Base":1,
"head and neck":2,
"propensity-score matching":1,
"TSH suppression":1,
"subclinical thyrotoxicosis":1,
"Hürthle cell carcinoma":1,
"TERT":3,
"pathologic size":1,
"ultrasound size":1,
"anaplastic thyroid cancer":3,
"thyroid surgery":4,
"undifferentiated":1,
"Low risk thyroid cancer":1,
"papillary microcarcinoma":2,
"staging":2,
"ABC transporter":1,
"Breast cancer resistant protein":1,
"Cabozantinib":3,
"Multidrug resistance":1,
"lesion-based dosimetry":1,
"response to radioiodine":1,
"thyroid cancer metastases":1,
"kinase inhibitors":1,
"re-differentiation":1,
"Afirma gene expression classifier":1,
"architectural atypia":1,
"cytologic atypia":1,
"indeterminate cytology":2,
"TERT promoter mutation":1,
"computed tomography":3,
"dog":1,
"thyroid mass":1,
"Anaplastic and papillary thyroid carcinoma":1,
"Carcinomes anaplasiques et papillaires de la thyroïde":1,
"Immunohistochimie":1,
"Marqueurs moléculaires":1,
"Molecular marker":1,
"convolutional neural network":1,
"detection":1,
"feature extraction":1,
"segmentation":1,
"ultrasound image":1,
"Beckman coulter":1,
"DxI platform":1,
"Immunoassay methods":1,
"Quality control":1,
"Quality specification":1,
"TSH":2,
"fine-needle aspiration (FNA)":3,
"noninvasive":1,
"molecular diagnostics":1,
"recent advances":1,
"aspiration cytology":1,
"cribriform adenocarcinoma of the minor salivary gland":1,
"head and neck cancer":2,
"Antiestrogen":1,
"GANT61":1,
"breast cancer stem cells":1,
"estrogen":1,
"hedgehog signaling pathway":1,
"Elasticity imaging, tissue":1,
"Imaging procedures":1,
"Liver":1,
"Tissue characterization":1,
"Tumor detection":1,
"Bladder":1,
"Lynch syndrome":1,
"Multiple primary tumor":1,
"Uterus":1,
"CD56":3,
"CK19":1,
"Mimicking thyroid lesions":1,
"Associated malignant tumor":1,
"Choroid plexus papilloma":1,
"Intraoperative consultation":1,
"Mature teratoma":1,
"Ovary":1,
"Postmenopausal women":1,
"atypical":1,
"interobserver":1,
"the Bethesda system":2,
"variability":1,
"CAD":1,
"Classification":1,
"Fractal features":1,
"Marginal fisher analysis":1,
"Aerobic glycolysis":1,
"CagA":1,
"cancer development":1,
"pyruvate kinase":1,
"gene expression":2,
"molecular genetics":2,
"EWSR1 rearrangement":1,
"EWSR1-FLI1":1,
"Ewing sarcoma":1,
"Small cell carcinoma":1,
"Non-squamous":1,
"Platinum-pemetrexed doublet":1,
"TTF1":2,
"Graves disease":1,
"Hashimoto thyroiditis":1,
"vitiligo":1,
"exfoliative cytology":1,
"nongynecologic cytology":1,
"quality assurance":1,
"Ductal carcinoma in situ":1,
"Multicenter study":1,
"primary thyroid lymphoma":1,
"primary thyroid sarcoma":1,
"bilateral breast approach":1,
"intraoperative neuromonitoring":1,
"percutaneous stimulation":1,
"recurrent laryngeal nerve":3,
"total endoscopic thyroidectomy":1,
"Extraskeletal myxoid chondrosarcoma":1,
"Molecular analysis":1,
"extension":1,
"extrathyroidal":1,
"minimal extrathyroidal extension":1,
"central compartment lymph nodes":1,
"lateral compartment lymph nodes":1,
"lymphatic pathways":1,
"prophylactic neck dissection":1,
"skip metastases":1,
"Focal liver lesions":1,
"Fusion imaging":1,
"Hepatocellular carcinoma (HCC)":1,
"Radiofrequency ablation (RFA)":1,
"Transarterial chemoembolization (TACE)":1,
"National Lung Screening Trial":1,
"body size":1,
"effective dose":1,
"low-dose CT":1,
"organ dose":1,
"multikinase inhibitor":1,
"noninterventional":1,
"observational":1,
"radioactive iodine refractory":1,
"sorafenib":2,
"MEN2":1,
"anxiety":1,
"depression":1,
"Lung adenocarcinoma":2,
"Pleural effusions":1,
"Acquired Subglottic Stenosis":1,
"Airway Obstruction":1,
"Tracheal Stenosis":1,
"Phase II":1,
"Advanced thyroid cancer":2,
"adverse events":1,
"molecular targets":1,
"Sistrunk procedure":1,
"thyroglossal duct cyst carcinoma":1,
"overtreatment":1,
"terminology":1,
"+49A&gt":1,
"G":2,
"-318C&gt":1,
"T":1,
"CT60A&gt":1,
"CTLA-4 gene":1,
"differentiated thyroid carcinoma":4,
"efficacy":1,
"radioiodine-131":1,
"focused ultrasound":1,
"nodule shrinkage":1,
"thermal ablation":1,
"core-needle biopsy":1,
"ultrasound imaging":1,
"BRAF V600E":1,
"HMGB1":1,
"ALK":1,
"mutations":3,
"new-generation sequencing":1,
"translocation":1,
"Anti-TNF agent":1,
"Axial spondyloarthritis":1,
"Multimodality":2,
"Surgical management":3,
"management guidelines":1,
"bilateral surgery":1,
"extensive thyroid cancer":1,
"intraoperative nerve monitoring":1,
"staged surgery":1,
"Didelphis virginiana":1,
"Virginia opossums":1,
"marsupial":1,
"neoplasia":2,
"Escin":1,
"pharmacokinetics":1,
"side effects":1,
"EGFR/ERK2":1,
"Warburg effect":1,
"iNOS":1,
"nitric oxide":1,
"Cystadenoma":1,
"Feline":1,
"Hashimoto's thyroiditis":1,
"subcentimeter nodules":1,
"Reporting":1,
"Surgical wait time":1,
"Endothelial dysfunction":1,
"Vascular endothelial growth factor":2,
"Comorbidities":1,
"Elderly":1,
"Molecular imaging":1,
"Prostate cancer":2,
"Radionuclide imaging":1,
"Radium-223":1,
"ER+":1,
"G1/S":1,
"MiR-206":1,
"WBP2":1,
"Cardiovascular diseases":1,
"Metformin":2,
"Non-diabetes":1,
"All-trans retinoic acid":1,
"Breast cancer cells":1,
"Docking protein 1":1,
"Peroxisome proliferator activated receptor gamma":1,
"IMRT":2,
"fixed collimator jaws technique":1,
"regional lymph node":1,
"Helicobacter pylori":1,
"TLR5":1,
"variation":2,
"PET":1,
"Cancer registries":1,
"EUROCARE":1,
"Europe":1,
"Relative survival":2,
"Docetaxel":1,
"STARD10":1,
"miR-638":1,
"Apaptosis":1,
"HSP90 inhibitor":2,
"NVP-AUY922":1,
"Survivin":2,
"CXCR1":1,
"CXCR2":1,
"Reparixin":1,
"DNA methylation":3,
"EZH2":1,
"METTL7A":1,
"gene body":1,
"Advanced cancer patient":1,
"Cyclin-dependent kinase inhibitors":1,
"Gemcitabine":1,
"Milciclib":1,
"FOXD3":1,
"MAPK/ERK signal pathway":1,
"human anaplastic thyroid cancer":1,
"Clinical and dosimetric predictors":1,
"Intensity-modulated radiotherapy":1,
"Nasopharyngeal carcinoma":2,
"Hyoid bone":1,
"adenocarcinoma metastases":1,
"computerized tomography bone scintigraphy":1,
"thyroid cartilage":2,
"Benign thyroid nodule":1,
"Ethanol":1,
"Image-guided ablation":1,
"Radiofrequency":1,
"Epidemiology":6,
"Non–small cell lung cancer":1,
"Surveillance":1,
"and End Results":1,
"race":1,
"socioeconomic status":1,
"celastrol":1,
"paclitaxel":1,
"synergism":1,
"Next-generation sequencing":1,
"endocrine cancer":2,
"4D CT":1,
"Lymph Nodes":1,
"Parathyroid Neoplasms":1,
"BRAFV600E mutation":2,
"FGF signaling pathway":1,
"Integrative analysis":1,
"Retinoic acid pathway":1,
"Children and adolescents":2,
"Clinical characteristics":1,
"Surgical treatment":1,
"hypergravity":1,
"microgravity":1,
"space environment":1,
"Incision":1,
"Lateral neck dissection":1,
"Lymph node dissection":1,
"Selective neck dissection":1,
"The Cancer Genome Atlas":2,
"Algorithm":1,
"Methods":2,
"Validation":2,
"Advanced cell renal carcinoma":1,
"Cancer bronchique non à petites cellules":1,
"Cancer de la prostate":1,
"Cancer du rein":1,
"Cancer médullaire de la thyroïde":1,
"MET receptor":1,
"Récepteur MET":1,
"99mTc-MDP bone scintillation imaging":1,
"99mTc-MIBI thyroid imaging":1,
"Metastatic pulmonary calcification":1,
"ARID2":1,
"Adenocarcinoma":1,
"Bladder cancer":1,
"Clear cells":1,
"DNA repair":2,
"Genetic susceptibility":1,
"MGMT":1,
"Radiation-induced cancer":1,
"Breast cancer screening":1,
"Childhood cancer":1,
"Childhood cancer survivor":1,
"Second cancer":1,
"Secondary cancer":1,
"Survivor":1,
"Thyroid cancer screening":1,
"Young age papillary thyroid cancer":1,
"Guidelines":1,
"Completion thyroidectomy":1,
"Hemithyroidectomy":1,
"Papillary thyroid microcarcinoma":4,
"Morbidity":1,
"Prophylactic central neck dissection":4,
"Medical malpractice":1,
"Recurrent laryngeal nerve injury":1,
"Atypia of undetermined significance":1,
"Fine needle cytology":2,
"Fine needle aspiration cytology":2,
"Molecular diagnosis":1,
"Carcinoma":2,
"99m Tc-MIBI scintigraphy":1,
"MIBI uptake":1,
"Radioguided surgery":1,
"Thyroid follicular neoplasm":1,
"RFA":1,
"Radiofrequency ablation":1,
"Radiofrequency thermal ablation":1,
"Adult intensive care":1,
"Cancer intervention":1,
"Geriatric medicine":1,
"Valvar diseases":1,
"arteriovenous malformation":1,
"presentation":1,
"renal cell cancer":1,
"unusual":1,
"cyclooxygenase 2":1,
"non-metastatic expressed/non-metastatic 23 nucleoside diphosphate kinase 1":1,
"B-Raf proto-oncogene":1,
"age":1,
"aggressiveness":1,
"size":1,
"tall cell variant":2,
"claudin 1":1,
"claudin 4":1,
"claudin 7":1,
"thyroid neoplasia":1,
"tight junctions":1,
"Pigment epithelium-derived factor":1,
"V-raf murine sarcoma viral oncogene homolog B1 V600E":1,
"CyberKnife M6™":1,
"Peripheral dose":1,
"Stereotactic radiosurgery":1,
"Cancer specific survival":1,
"Disease free interval":1,
"Hurthle cell carcinoma":1,
"adult thyroid":1,
"cardiovascular":1,
"clinical":1,
"general":1,
"Coblation":1,
"Surgical procedures, minimally invasive":1,
"Tongue neoplasms":1,
"Hypopharyngeal cancer":1,
"Laryngeal neoplasm":1,
"Magnetic resonance imaging":1,
"High throughput sequencing":1,
"Log-rank test":1,
"Rule induction":1,
"Separate-and-conquer":1,
"HOX transcript antisense RNA":1,
"biomarker":3,
"long non-coding RNAs":1,
"Calcium and bone":1,
"Metabolic disorders":2,
"Laparoscopic":1,
"Pancreas metastasis":1,
"Pancreatectomy":1,
"Regional recurrence":1,
"I-131":1,
"benign stenosis":1,
"drug-eluting stents":1,
"stents":1,
"Demography":1,
"Iran":1,
"Actinomycosis":1,
"Fistula":1,
"undifferentiated thyroid cancer":1,
"medullary thyroid":1,
"CK5/6":1,
"Histological classification":1,
"NapsinA":1,
"P63":3,
"Chromogranin":1,
"Pan cytokeratin":1,
"Synaptophysin":2,
"Genetic therapy":1,
"Palliative care":1,
"Patient comfort":1,
"Ectopic thyroid":1,
"MRI":1,
"Follicular Adenoma":3,
"Galactin-3":1,
"Neuroendocrine tumors":2,
"small cell neuroendocrine carcinoma":1,
"small round blue cell tumors":1,
"TSHR mRNA":1,
"noninvasive detection":1,
"peripheral blood":1,
"Helicobacter pylori infection":1,
"disadvantaged population":1,
"social determinants of health":1,
"socioeconomic development":1,
"urban-rural disparity in cancer":1,
"urbanization":1,
"FDG-avid":1,
"Oncocytoma":1,
"PET/CT":1,
"Renal mass":1,
"capillarity":1,
"fine-needle biopsy":1,
"Cowden syndrome":2,
"PTEN":3,
"ganglioneuroma":1,
"hamartoma":1,
"osteosarcoma":1,
"CaSR":1,
"p27 Kip1":1,
"malignant solitary fibrous tumor":1,
"thyroid tumor":1,
"inflammatory myofibroblastic tumor":1,
"fatigue":1,
"patient reported outcome measures":1,
"survivals":1,
"DNA analysis":1,
"Follicular neoplasms":1,
"Thyroid FNA":1,
"miRNAs":1,
"Extramedullary plasmacytoma":1,
"HIV infection":1,
"Ureter":1,
"CD14":1,
"Innate immunity":1,
"Pattern recognition receptor":1,
"Toll like receptor":1,
"Consanguinity":1,
"Druze":1,
"Incidence rates":1,
"Israel":2,
"Filipino":1,
"metastatic":1,
"oral":1,
"Adenocarcinomas":1,
"ETV6-NTRK3":1,
"Mammary analog secretory carcinoma":1,
"Salivary gland-type carcinomas":1,
"Thyroid paraganglioma":1,
"graves":1,
"hematoma":2,
"toxic nodular goitre":1,
"Cervical sympathetic trunk":1,
"Deep lobe of parotid gland":1,
"External carotid artery":1,
"First bite syndrome":1,
"Parapharyngeal space":1,
"Anaplastic thyroid carcinoma (ATC)":1,
"Anaplastic transformation":1,
"Papillary thyroid carcinoma (PTC)":3,
"Pleural metastasis":1,
"Carcinoma, papillary/pathology":1,
"Follow-up studies":2,
"Thyroglossal cyst/epidemiology":1,
"Thyroglossal cyst/pathology":1,
"Thyroglossal cyst/surgery":1,
"Thyroid neoplasms/pathology":1,
"131-I":1,
"SPECT/CT":1,
"Whole body scan":1,
"Risk classification":1,
"DIAGNOSTICS":1,
"LABORATORY TESTS":1,
"MOLECULAR ONCOLOGY":1,
"head neck cancer":1,
"radiation-induced hypothyroidism":1,
"Fukushima Daiichi nuclear power plant accident":1,
"health survey":1,
"physician training":1,
"pre-distribution":1,
"stable iodine administration":1,
"Adjuvant RAI":1,
"Lymphadenectomy":2,
"Molecular markers":3,
"RAI":2,
"Screening":2,
"NPC":1,
"MV-CBCT":1,
"secondary cancers":1,
"Survivorship":1,
"Brazil":1,
"cervical cancer":1,
"low–intermediate income countries":1,
"trends":1,
"Postoperative concurrent chemoradiotherapy":1,
"Thyroid function after radiotherapy":1,
"Total laryngectomy":1,
"Total pharyngo-laryngo-esophagectomy":1,
"Adjuvant chemotherapy":1,
"Capecitabine":1,
"Feasibility study":1,
"Japanese":1,
"X-ACT trial":1,
"prevalence":1,
"serum uric acid":1,
"BRAF K601E":1,
"thyroid pathology":1,
"Attention":1,
"Breast neoplasms":1,
"Cognition":1,
"Compensatory cognitive training":1,
"Memory":1,
"diagnostic performance":1,
"shear wave elastography (SWE)":1,
"thyroid imaging reporting and data system (TI-RADS)":1,
"“tandem” and “parallel”":1,
"Adult":2,
"Pediatric":1,
"apatinib":1,
"maximum standard uptake value":1,
"radioiodine refractory differentiated thyroid cancer":1,
"safety":2,
"Bax":1,
"Caspase-3":1,
"Caspase-9":1,
"Dimethylbenz(a)anthracene":1,
"Graves’ disease":1,
"cytological alteration":1,
"histologic changes":1,
"radioactive iodine treatment":1,
"Lymph node metastasis":4,
"Predictor":1,
"adrenal gland":1,
"autofluorescence":1,
"parathyroid gland":1,
"Multivariate analysis":1,
"PCA":1,
"Apoptosis induction":1,
"Cidofovir":1,
"Cytokine":1,
"Inflammatory disease":1,
"Interleukin-32 (IL-32)":1,
"Spliced isoforms":1,
"Therapeutic approaches":1,
"Chemotherapy and chemoradiotherapy":1,
"Circulating tumor cells":1,
"Liquid biopsy":1,
"The CellSearch system":1,
"Ambient mass spectrometry":1,
"Cancer staging":1,
"Lipid profiles":1,
"Mass spectrometry imaging":1,
"Metastatic cancer":1,
"MASC":1,
"BRAF(V600E) inhibitor":1,
"Bcl2 family protein":1,
"Orthotopic model":1,
"PET-positive":1,
"incidental nodules":1,
"Asia Cohort Consortium":1,
"Asians":1,
"Cancer mortality":1,
"Type 2 diabetes":2,
"accuracy":1,
"touch imprint cytology":1,
"131I therapy":1,
"mathematical modeling":1,
"radiation protection":1,
"radiation safety":1,
"radiopharmaceutical therapy":1,
"Growth inhibition":1,
"Telomerase":2,
"siRNA":1,
"postoperative thyroglobulin":1,
"prognostic factors":2,
"Long-term survival":1,
"Mitosis":1,
"Tumor necrosis":1,
"EML4-ALK":1,
"PAX8-PPARgamma":1,
"TFG-MET":1,
"clear-cell thyroid carcinoma":1,
"genetic alterations":2,
"racial disparities":1,
"temporal trends":1,
"cytomorphology":1,
"noninvasive encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC)":1,
"Clonal relationship":1,
"Multifocal papillary thyroid carcinoma":1,
"Multifocality":1,
"Whole genome sequencing":2,
"Allele-specific PCR":1,
"Allele-specific copy number":1,
"cancer evolution":1,
"metastatic colorectal carcinoma":1,
"mutational analysis":1,
"phylogenetic tree":1,
"synchronous metastases":1,
"Computer-assisted interventions":1,
"Electromagnetic tracking":1,
"Thyroid radiofrequency ablation":1,
"Ultrasound guidance":1,
"encapsulated follicular variant of papillary thyroid carcinoma":1,
"invasive follicular variant of papillary thyroid carcinoma":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":2,
"thyroid ultrasound":2,
"SIRs":1,
"second primary malignancy":1,
"Adolescents":1,
"CT":1,
"Incidentaloma":1,
"TNM staging":2,
"delayed risk stratification":1,
"extrathyroidal invasion":1,
"neoplasm invasion":1,
"NTRK3":1,
"fusion gene":1,
"oncogene":2,
"TSH receptor":1,
"theranostics":1,
"Continental Population Groups":1,
"columnar cell variant":1,
"differential diagnosis":1,
"Thyroglobulin measurement":1,
"Thyroglobulin stability":1,
"Thyroid nodes":1,
"Washout of fine needle aspiration biopsies":1,
"CBX7":1,
"DKK1":1,
"glioma":1,
"wnt/β-catenin pathway":1,
"mathematical model":1,
"metastatic thyroid cancer":1,
"personalized medicine":1,
"radioactive iodine therapy":1,
"therapeutic nuclear medicine":1,
"Diabetes mellitus":1,
"Sedentary lifestyle":1,
"adrenocortical cancer":1,
"phaeochromocytoma":1,
"pituitary carcinoma":1,
"prospective study":1,
"remnant ablation":1,
"thyroid TIRADS":1,
"thyroid guidelines":1,
"FATS":1,
"genetics":1,
"hereditary tumors":2,
"Thyroid lobectomy":1,
"low-grade mucoepidermoid tumor":1,
"parotid":1,
"Endocrine tumor":1,
"Central neck dissection":2,
"Airway":1,
"Locally invasive":1,
"Clusterin":1,
"Endocrine tumors":1,
"Thyroid tumors":1,
"PEBP4":1,
"PI3K/Akt pathway":2,
"risk":1,
"gene expression profiling":1,
"CCR2 antagonist":1,
"MMP-9":1,
"motility and invasion":1,
"non-small cell lung cancer":1,
"viability":1,
"Hormone replacement therapy":1,
"Oral contraceptives":1,
"Reproductive history":1,
"100&nbsp":1,
"mSv threshold":1,
"Ethics":1,
"Fukushima nuclear power plant accident":1,
"Linear no-threshold":1,
"Risk communication":1,
"NRAS":1,
"Q61R":1,
"colorectal carcinoma":1,
"Acoustic radiation force impulse":1,
"Shear wave elastography imaging":1,
"SLC2A1":1,
"glycolysis":1,
"microRNA-148b":1,
"canalicular adenoma":1,
"intra-operative frozen section diagnosis":1,
"intra-tumoral hematoma":1,
"papillary thyroid carcinoma-like histology":1,
"striated duct adenoma":1,
"Capsular invasion":1,
"Capsule":1,
"pregnancy":2,
"tumor growth":1,
"hypocalcemia":1,
"outcomes":1,
"Percentage difference":1,
"Tumor size":1,
"Ultrasonography diameter":1,
"human papillomavirus":1,
"lung":1,
"mixed squamous and glandular papilloma":1,
"p16Ink4a":1,
"Right para-oesophageal lymph node (RPELN)":1,
"ganetespib":1,
"Gene fusion":1,
"PTEN hamartoma tumor syndrome":1,
"Central lymph node metastasis":2,
"Curage cervical central prophylactique":1,
"Microcarcinome papillaire thyroïdien":1,
"Stadification TNM":1,
"Stratification du risque":1,
"CYP1A2":1,
"Dioxin receptor":1,
"Receptors cross-talk":1,
"S14":1,
"drug delivery":1,
"extracorporeal shock waves":1,
"nanobubbles":1,
"growth differentiation factor 15":1,
"MDM2-p53 interaction":1,
"anti-tumor":1,
"dedifferentiated thyroid cancer":1,
"ABO blood type":1,
"Young breast cancer":1,
"And thyroid cancer":1,
"Genetic instability":1,
"Homologous recombinant repair":1,
"Over expression":1,
"Proliferation marker":1,
"GAS5":1,
"Long non-coding RNA":1,
"Rac1":1,
"WxxxE motif":1,
"anti-cancer polypeptide":1,
"azurin protein":1,
"ALA":1,
"DHLA":1,
"PTP1B":1,
"SHP2":1,
"lipoic acid":1,
"follicular thyroid adenoma":1,
"follicular thyroid cancer":1,
"IFNγ":1,
"cytokine signaling":1,
"phosphatidylserine":1,
"quantitative biology":1,
"transcriptional regulation":1,
"tumor inflammation":1,
"tumor microenvironment":1,
"Head and neck surgery":1,
"Thyroid disease":2,
"Recurrent laryngeal nerves":1,
"Vocal cord paralysis":1,
"Boron":1,
"Cadmium":1,
"Heavy metals":1,
"Metalloids":1,
"Molybdenum":1,
"Volcanic area":1,
"Sleeping Beauty":1,
"Swi/Snf":1,
"thyroid cancer genomics":1,
"18F-fluorodeoxyglucose (18F-FDG)":1,
"differentiated thyroid cancer (DTC)":1,
"positron emission tomography/computed tomography (PET/CT)":1,
"post-therapeutic 131I whole-body scan (131I-WBS)":1,
"serum thyroglobulin (Tg)":1,
"thyroid-stimulating hormone (TSH)":1,
"TT-1":1,
"Interferon-α (IFN-α)":1,
"Natural killer (NK) cells":1,
"Hepatocarcinoma":1,
"Pituitary, Adrenal, Incidentaloma":1,
"Human telomerase reverse transcriptase gene":1,
"Postoperative recurrence":1,
"Nodular goiter":1,
"Poorly differentiated thyroid carcinoma":1,
"RAS mutation":1,
"renal":1,
"FOLFIRINOX":1,
"lipase hypersecretion syndrome":1,
"pancreatic acinar cell carcinoma":1,
"pancreatic panniculitis":1,
"Texture analysis":1,
"Texture feature":1,
"circulating biomarkers":1,
"Carcinoma diferenciado de tiroides":1,
"Incidencia cáncer tiroides":1,
"Microcarcinoma":1,
"Thyroid carcinoma incidence":1,
"flavonoid":1,
"invasiveness":1,
"iodide uptake":1,
"phytochemical":1,
"radioiodine therapy":3,
"sodium iodide symporter (NIS)":1,
"The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)":1,
"ThyGenX":1,
"ThyraMIR":1,
"ThyroSeq":1,
"Reoperative central neck dissection":1,
"Video-assisted central neck dissection":1,
"Mature ovarian teratoma":1,
"healthcare delivery":1,
"DNA damage":1,
"genetic material stability":1,
"thyroid stunning":1,
"Parvovirus B19":1,
"interleukin 6":1,
"non-structural protein 1":1,
"nuclear factor kappa B":1,
"tumor necrosis factor alpha":1,
"MAPK":1,
"Central lymph node dissection":1,
"Prelaryngeal lymph node metastasis":1,
"Pretracheal lymph node metastasis":1,
"Non-small-cell lung cancer":1,
"Lateral pelvic lymph nodes":1,
"Lower rectal cancer":1,
"Micrometastasis":1,
"Sentinel nodes":1,
"Pathology, clinical":2,
"Multifocal tumor":1,
"RET/ PTCrearrangement":1,
"Bisphenol A":1,
"Icarrin":1,
"Superoxide dismutase":1,
"Epithelium":1,
"Pax2":1,
"Pax8":1,
"Therapy":1,
"p53 inhibition mechanisms":1,
"p73":1,
"target therapies":1,
"Differentiated thyroid cancers (DTC)":1,
"Local anesthesia":1,
"Gender inequality":1,
"MiR-608":1,
"rs4919510":1,
"Adrenal disorders":1,
"Endocrinology":1,
"Psychiatry":1,
"RTK inhibitor":1,
"c-Met signalling":1,
"valproic acid":1,
"EMT":1,
"HCC":1,
"SOX12":1,
"miR-874":1,
"cell-free DNA":1,
"integrity index":1,
"plasma":1,
"qPCR":1,
"Humans":1,
"Philippines":1,
"Retrospective studies":1,
"Survival rate":1,
"Core needle biopsy":1,
"rapid on-site evaluation":1,
"completion lymphadenectomy":1,
"tall-cell variant":1,
"Adjuvant":1,
"Trachea":1,
"Bilateral axillo-breast approach (BABA)":2,
"modified radical neck dissection (MRND)":1,
"robot":1,
"endocrine surgical procedures":1,
"robotics":1,
"PR":1,
"iodine radioisotopes":1,
"Medullary thyroid carcinoma (MTC)":1,
"multiple endocrine neoplasia type 2 (MEN2)":1,
"prophylactic thyroidectomy":1,
"rearranged during transfection (RET)":1,
"Calcifications":1,
"Centricity":1,
"Clinicopathological features":1,
"B-CPAP cell line":1,
"TERT mutation":1,
"thyrosphere":1,
"TSH feedback control":1,
"deiodinase":1,
"levothyroxine treatment":1,
"set point":1,
"thyroid homeostasis":1,
"Biopsy, Fine-Needle":1,
"metastatic disease":1,
"radio iodine":1,
"refractory thyroid cancer":1,
"doubling time":1,
"growth curves":1,
"inflection point":1,
"MEN":1,
"TKI":2,
"tyrosine kinase":1,
"RECIST":1,
"oncogenes":1,
"protein kinases":1,
"gastrointestinal":1,
"hypertension":1,
"chronic lymphocytic thyroiditis":1,
"ABI3":1,
"CYFIP1":1,
"PI3K/AKT":1,
"WAVE2":1,
"intratumoral IL-17A overexpression":1,
"solid tumor":1,
"worse outcome":1,
"evolution":1,
"genomics":1,
"selection":1,
"Cushing syndrome":1,
"neuroendocrine tumours":1,
"pancreatic neoplasms":1,
"Hyperparathyroidism":1,
"PTH":1,
"Parathyroid cyst":1,
"Parathyroid hormone":1,
"Somalia":1,
"cancer distribution":1,
"esophagus cancer":1,
"CK7":1,
"HMWK":1,
"lung carcinoma":1,
"AMP-activated protein kinase":1,
"gene knockout":1,
"mice model":1,
"differential thyroid carcinoma":1,
"skull base":1,
"endoplasmic reticulum stress":1,
"extracellular protein kinase 2":1,
"nuclear factor erythroid-2 related factor 2":1,
"p-ERK½":1,
"D-dimer":1,
"Small-cell lung cancer":1,
"Therapeutic effect":1,
"androgen receptor":1,
"nonsquamous cell carcinoma":1,
"preliminary study":1,
"epidemiologic research design":1,
"patient participation rates":1,
"registries":1,
"research subject recruitment":1,
"surveys and questionnaires":1,
"Fine-needle aspiration biopsy-FNAB":1,
"follicular cancer":1,
"papillary cancer":1,
"scintigraphy":1,
"solitary thyroid nodule":1,
"cancer of the hypopharynx":1,
"head and neck spindle cell carcinoma":1,
"sarcomatoid carcinoma":1,
"spindle cell carcinoma":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年第2季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
